Medical News

RSS

Graymark Healthcare 2010 net revenues increase 30% to $22.8 million

Graymark Healthcare, Inc., the nation's second largest provider of diagnostic sleep services and an innovator in comprehensive care for obstructive sleep apnea (OSA), reported financial results for the fiscal year ended December 31, 2010.

28 Mar 2011

WaferGen launches SmartChip Human microRNA Panel V2 for gene expression profiling

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, today announced the launch of its industry-leading SmartChip Human microRNA Panel V2 for gene expression profiling on the SmartChip Real-Time PCR System.

28 Mar 2011

Quest Diagnostics subsidiary initiates tender offer for Celera acquisition

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced today it has commenced a tender offer through its wholly owned subsidiary, Spark Acquisition Corporation, for all of the outstanding shares of common stock (the "Shares") of Celera Corporation (Nasdaq: CRA), one of the world's pioneers in genetic diagnostics discovery and development for $8.00 per share in cash, without interest and less any required withholding taxes.

From Quest Diagnostics 28 Mar 2011

New pill may protect DNA from radiation damage

The Japanese nuclear crisis has caused a surge in the demand of potassium iodide, causing shortages not only in Japan, but as far away as California, western Canada, and even southeastern Russia. Although potassium iodide does not provide generalized radiation protection because it only shields the thyroid, manufacturers and pharmacies are being bombarded with orders as the radiation hysteria mounts.

28 Mar 2011

Biotectix acquires Chameleon BioSurfaces technology

Biotectix, LLC announced today the acquisition of all significant assets owned by Chameleon BioSurfaces Ltd. (Cambridge, United Kingdom). Financial terms were not disclosed.

28 Mar 2011

Dosing commences in Phase I clinical study of GenSpera's G-202 at Cancer Therapy & Research Center

GenSpera, Inc. announced that the first patient was dosed in the ongoing Phase I clinical study of its chemotherapeutic agent, G-202, at the Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio in San Antonio, Texas.

28 Mar 2011

Hospital pricing, mergers grab headlines

In Texas, reports indicate that costs vary widely by hospital. Meanwhile, merger talks begin in Connecticut.

28 Mar 2011

GE Healthcare launches Centricity Research, a new clinical research management solution

GE Healthcare, a global leader in healthcare information technology, today announced Centricity Research, a new clinical research management solution (CRMS). Centricity Research will help improve the efficiency and efficacy of clinical research studies, enterprise-wide, by driving better management of treatment plans, processes, and protocols while supporting research billing compliance.

28 Mar 2011

Helix BioMedix 2010 total revenue increases 118% to $852,000

Helix BioMedix, Inc., a developer of bioactive peptides, today announced financial results for the year ended December 31, 2010.

28 Mar 2011

Pathway Medical initiates enrollment in JETSTREAM G3 Calcium Study in peripheral artery disease

Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral vascular disease (PVD), today announced enrollment of the first patient in the company's JETSTREAM G3 Calcium Study, a prospective, single-arm, multi-center registry to evaluate the treatment effects of the JETSTREAM G3 System in patients with moderate to severely calcified peripheral artery disease.

28 Mar 2011

Exploring the donor kidney market

Should you be paid to part with a kidney?

28 Mar 2011

Phase 2a study of DARA BioSciences KRN5500 in treatment of cancer pain reaches primary end-point

Researchers studying a new medication for neuropathic pain have reported intriguing findings about placebo response versus drug response from a Phase 2a proof-of-concept study. They presented their findings in a poster session at the 2011 International Conference on Accelerating the Development of Enhanced Pain Treatments.

28 Mar 2011

First Edition: March 25, 2011

Today's headlines include reports about mini-med plans and accountable care organizations as well as the ongoing impasse in Congress regarding current year spending.

28 Mar 2011

Cancer drug Gleevec may hold promise against scleroderma: Study

A drug approved to treat certain types of cancer has shown promising results in the treatment of patients with scleroderma, according to results from an open-label Phase II trial. While the drug's efficacy must be demonstrated in a Phase III trial, the gold standard for testing a drug, researchers are optimistic that Gleevec- (imatinib) could potentially be a weapon against the chronic connective tissue disease for which a treatment has remained elusive.

28 Mar 2011

Metagenics announces 2011 schedule for educational programs in lifestyle medicine

Metagenics Inc., a nutrigenomics and lifestyle medicine company dedicated to reducing chronic illness and improving health, announced today the 2011 schedule for educational programs in lifestyle medicine as well as for certification programs for its FirstLine Therapy, a turnkey, lifestyle medicine program.

28 Mar 2011

Chembio develops DPP assay for rapid detection of HIV and HEP B/C

A kidney recipient in a New York City hospital recently contracted HIV from the transplanted organ, which came from a living donor, according to the New York State Department of Health. Although an initial screening had been performed on the donor, he or she apparently had unsafe sex after the test but before donating the kidney.

28 Mar 2011

Asbury Communities offers management and support services for older adults

In 2010, more than 4 million baby boomers turned 50, according to the U.S. Census Bureau. Boomers today represent 28 percent of the U.S. population, or 76.1 million people. With so many people aging, how is the senior living industry going to provide services to this group of older Americans?

28 Mar 2011

MolecularMD and ARIAD collaborate to develop and commercialize CML, ALL diagnostic test

ARIAD Pharmaceuticals, Inc. and MolecularMD Corporation today announced an exclusive collaboration agreement in which MolecularMD will develop and commercialize a companion diagnostic test to identify the T315I mutation of the BCR-ABL gene in patients with chronic myeloid leukemia and Philadelphia positive acute lymphoblastic leukemia.

28 Mar 2011

First open fetal surgery to treat lung malformations performed at Texas Children's Hospital

Experts from Texas Children's Fetal Center published a study that appears in volume 46, issue 2 of the Journal of Pediatric Surgery documenting the first successful cases of open fetal surgery to treat fetal lung malformations in the Southern U.S.

28 Mar 2011

SHOM selects Scott & Co to audit Company's financials for past two years

Southern Home Medical Equipment, Inc., a Holding Company providing healthcare services, healthcare professionals and equipment to medical institutions, has selected Scott & Company, a Public Company Accounting Oversight Board approved accounting firm in Columbia, SC, to audit the Company's financials for the past two years and provide additional accounting services to the Company.

28 Mar 2011

Medical News

Graymark Healthcare 2010 net revenues increase 30% to $22.8 million

WaferGen launches SmartChip Human microRNA Panel V2 for gene expression profiling

Quest Diagnostics subsidiary initiates tender offer for Celera acquisition

New pill may protect DNA from radiation damage

Biotectix acquires Chameleon BioSurfaces technology

Dosing commences in Phase I clinical study of GenSpera's G-202 at Cancer Therapy & Research Center

Hospital pricing, mergers grab headlines

GE Healthcare launches Centricity Research, a new clinical research management solution

Helix BioMedix 2010 total revenue increases 118% to $852,000

Pathway Medical initiates enrollment in JETSTREAM G3 Calcium Study in peripheral artery disease

Exploring the donor kidney market

Phase 2a study of DARA BioSciences KRN5500 in treatment of cancer pain reaches primary end-point

First Edition: March 25, 2011

Cancer drug Gleevec may hold promise against scleroderma: Study

Metagenics announces 2011 schedule for educational programs in lifestyle medicine

Chembio develops DPP assay for rapid detection of HIV and HEP B/C

Asbury Communities offers management and support services for older adults

MolecularMD and ARIAD collaborate to develop and commercialize CML, ALL diagnostic test

First open fetal surgery to treat lung malformations performed at Texas Children's Hospital

SHOM selects Scott & Co to audit Company's financials for past two years

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News